ETOP IBCSG Partners Foundation

🇨🇭Switzerland

Country: 🇨🇭Switzerland

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Study of Changes in Estrogen Levels and Grip Strength in Postmenopausal Women Who Have Received 4 to 6 Years of Hormone Therapy for Breast Cancer and Are Currently Receiving Letrozole on Clinical Trial IBCSG-35-07

Completed

Conditions: Breast Cancer

First Posted Date: 2011-01-21

Last Posted Date: 2021-10-06

Lead Sponsor: ETOP IBCSG Partners Foundation

Target Recruit Count: 104

Registration Number: NCT01281137

Locations: 🇦🇺
Box Hill Hospital, Box Hill, Victoria, Australia
🇧🇪
CHU Liege - Domaine Universitaire du Sart Tilman, Liege, Belgium

Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Other: gas chromatography / tandem mass spectometry

First Posted Date: 2009-09-11

Last Posted Date: 2021-10-25

Lead Sponsor: ETOP IBCSG Partners Foundation

Target Recruit Count: 123

Registration Number: NCT00975676

Locations: 🇫🇷
Centre Rene Huguenin, Saint-Cloud, France
🇪🇸
Vall d'Hebron University Hospital, Barcelona, Spain
🇵🇹
Centro de Lisboa, Lisboa, Portugal

and more 21 locations

Study of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02

Not Applicable

Active, not recruiting

Conditions: Osteoporosis
Breast Cancer

Interventions: Other: laboratory biomarker analysis
Procedure: dual x-ray absorptiometry

First Posted Date: 2009-08-21

Last Posted Date: 2023-05-31

Lead Sponsor: ETOP IBCSG Partners Foundation

Target Recruit Count: 119

Registration Number: NCT00963417

Locations: 🇧🇪
UZ Leuven, Leuven, Belgium
🇧🇪
Centre Hospitalier Regional de Huy, Huy, Belgium
🇦🇺
Peter MacCallum Cancer Center, East Melbourne, Australia

and more 10 locations

Fingernails in Evaluating Bone Health in Postmenopausal Women With Breast Cancer Undergoing Hormone Therapy on Clinical Trial IBCSG-1-98

Phase 3

Terminated

Conditions: Breast Cancer
Osteoporosis

Interventions: Procedure: spectroscopy

First Posted Date: 2009-05-12

Last Posted Date: 2012-07-27

Lead Sponsor: ETOP IBCSG Partners Foundation

Target Recruit Count: 60

Registration Number: NCT00899288

Brain Function in Premenopausal Women Receiving Tamoxifen With or Without Ovarian Function Suppression for Early-Stage Breast Cancer on Clinical Trial IBCSG 24-02

Phase 3

Completed

Conditions: Fatigue
Breast Cancer
Sleep Disorders

Interventions: Drug: Tamoxifen
Drug: triptorelin
Drug: Exemestane

First Posted Date: 2008-04-16

Last Posted Date: 2016-07-25

Lead Sponsor: ETOP IBCSG Partners Foundation

Target Recruit Count: 86

Registration Number: NCT00659373

Locations: 🇺🇸
Front Range Cancer Specialists, Fort Collins, Colorado, United States
🇺🇸
New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care, Concord, New Hampshire, United States
🇺🇸
Batte Cancer Center at Northeast Medical Center, Concord, North Carolina, United States

and more 12 locations

Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Drug: Letrozole

First Posted Date: 2007-11-04

Last Posted Date: 2020-03-11

Lead Sponsor: ETOP IBCSG Partners Foundation

Target Recruit Count: 4884

Registration Number: NCT00553410

Locations: 🇨🇭
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
🇦🇹
Innsbruck Universitaetsklinik, Innsbruck, Austria
🇺🇸
Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute, Boston, Massachusetts, United States

and more 160 locations

Bone Density and Bone Loss in Postmenopausal Women With Breast Cancer Receiving Treatment in Clinical Trial IBCSG-1-98

Phase 3

Completed

Conditions: Breast Cancer
Osteoporosis

Interventions: Other: laboratory biomarker analysis
Procedure: Dual energy X-ray absorptiometry (DEXA)
Procedure: Spine X-ray

First Posted Date: 2006-08-29

Last Posted Date: 2012-07-27

Lead Sponsor: ETOP IBCSG Partners Foundation

Target Recruit Count: 458

Registration Number: NCT00369850

Locations: 🇨🇭
Kantonsspital - St. Gallen, St. Gallen, Switzerland
🇨🇭
Regionalspital, Thun, Switzerland
🇪🇸
Hospital Ruber Internacional, Madrid, Spain

and more 13 locations

Cognitive Function in Postmenopausal Women With Breast Cancer Receiving Hormone Therapy on Clinical Trial IBCSG-1-98

Phase 3

Completed

Conditions: Cognitive/Functional Effects
Psychosocial Effects of Cancer and Its Treatment
Breast Cancer
Fatigue

Interventions: Procedure: cognitive assessment
Procedure: fatigue assessment and management
Procedure: psychologic distress
Procedure: quality-of-life assessment

First Posted Date: 2006-06-23

Last Posted Date: 2012-07-27

Lead Sponsor: ETOP IBCSG Partners Foundation

Target Recruit Count: 135

Registration Number: NCT00343616

Locations: 🇦🇺
Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
🇦🇺
Institute of Oncology at Prince of Wales Hospital, Randwick, New South Wales, Australia
🇧🇪
Institut Jules Bordet, Brussels, Belgium

and more 9 locations

Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS

Phase 3

Withdrawn

Conditions: Breast Cancer
Osteoporosis

First Posted Date: 2006-05-11

Last Posted Date: 2012-11-29

Lead Sponsor: ETOP IBCSG Partners Foundation

Registration Number: NCT00324714

Locations: 🇨🇭
Inselspital Bern, Bern, Switzerland
🇨🇭
Oncocare Sonnenhof-Klinik Engeriedspital, Bern, Switzerland

Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast Cancer

Phase 3

Terminated

Conditions: Breast Cancer

Interventions: Drug: pegylated liposomal doxorubicin hydrochloride
Drug: cyclophosphamide
Drug: methotrexate
Radiation: radiation therapy
Procedure: adjuvant therapy

First Posted Date: 2006-02-24

Last Posted Date: 2021-02-23

Lead Sponsor: ETOP IBCSG Partners Foundation

Target Recruit Count: 77

Registration Number: NCT00296010

Locations: 🇧🇪
Centre Hospitalier Etterbeek Ixelles, Brussels, Belgium
🇧🇪
AZ Groeninge - Oncologisch Centrum, Kortrijk, Belgium
🇧🇪
Institut Jules Bordet, Brussels, Belgium

and more 30 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy